Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-bren vs Platinum-based Chemotherapy in HER2+ Metastatic Urothelial Cancer
NCT07869836Phase 3Recruiting
- Sponsor
- SystImmune Inc.
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 3 trial of T-Bren in urothelial carcinoma (UC), sponsored by SystImmune Inc.. Started Sep 2026; status: recruiting.
02
Drugs
T-Bren
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT07869836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869836.